1.Barohn RJ., Kissel JT., Warmolts JR., Mendell JR. Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical character-istics, course, and recommendations for diagnostic criteria. Arch Neurol. 1989. 46:878–884.
2.Katz JS., Saperstein DS., Gronseth G., Amato AA., Barohn RJ. Distal acquired demyelinating symmetric neuropathy. Neurology. 2000. 54:615–620.
Article
3.Dimachkie MM., Barohn RJ., Katz J. Multifocal motor neuropathy, multifocal acquired demyelinating sensory and motor neuropathy, and other chronic acquired demyelinating polyneuropathy variants. Neurol Clin. 2013. 31:533–555.
Article
4.O’Leary CP., Willison HJ. The role of antiglycolipid antibodies in peripheral neuropathies. Curr Opin Neurol. 2000. 13:583–588.
Article
5.Larue S., Bombelli F., Viala K., Neil J., Maisonobe T., Bouche P, et al. Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases. Eur J Neurol. 2011. 18:899–905.
Article
6.Remiche G., Kentos A., Mavroudakis N. Distal acquired demyelinating symmetric neuropathy associated with anti-GM1 antibod-ies: is this a CIDP variant? Acta Neurol Belg. 2010. 110:103–106.
7.Saperstein DS., Katz JS., Amato AA., Barohn RJ. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve. 2001. 24:311–324.
Article
8.Nobile-Orazio E., Manfredini E., Carpo M., Meucci N., Monaco S., Ferrari S, et al. Frequency and clinical correlates of anti-neuronal IgM antibodies in neuropathy associated with IgM monoclonal gammopathy. Ann Neurol. 1994. 36:416–424.
9.Quarles RH., Weiss MD. Autoantibodies associated with peripheral neuropathy. Muscle Nerve. 1999. 22:800–822.
Article
10.Rinaldi S., Willison HJ. Ganglioside antibodies and neuropathies. Curr Opin Neurol. 2008. 21:540–546.
Article